Receive our newsletter – data, insights and analysis delivered to you
  1. News
July 30, 2020

Eargo raises $71m to expand commercialisation of hearing loss solution

Eargo, a US-based medical device company, has raised $71m in an equity financing round to accelerate the commercialisation of its direct-to-consumer hearing loss solution.

Eargo, a US-based medical device company, has raised $71m in an equity financing round to accelerate the commercialisation of its direct-to-consumer hearing loss solution.

The financing round was led by new co-investors Gilde Healthcare and Longitude Capital. It was also joined by the company’s existing investors New Enterprise Associates (NEA), the Charles and Helen Schwab Foundation and Nan Fung Life Sciences.

Gilde Healthcare general partner Geoff Pardo and Longitude Capital founder and managing director Juliet Bakker will join Eargo’s board of directors as part of the deal.

Eargo offers virtually invisible, rechargeable, completely-in-canal, the Food and Drug Administration (FDA)-regulated, exempt Class I hearing aid, along with online hearing screening and telecare consultation and support.

Consumers can purchase the solution online or over the phone. They can also have personalised consultation and support from licensed hearing professionals through phone, text, email or video chat.

Eargo president and CEO Christian Gormsen said: “We are pleased to close on this financing round, which provides us with significant capital to fund our growth. While our business was performing well before Covid-19, the pandemic accelerated consumer demand for our hearing loss solution.

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 

“More consumers who are reluctant to purchase their hearing aids through the traditional brick and mortar clinics have recognised the benefits of our solution.”

It is estimated that approximately 43 million people suffer from hearing loss in the US. However, only 27% of the affected people own hearing aid due to the stigma and inconvenience of the traditional clinic-based model.

Geoff Pardo said: “Eargo has revolutionised the hearing loss solution, offering a highly advanced hearing solution available through a virtual clinic model. We are excited to be a part of the Eargo team and their vision to transform this market, bringing it into the 21st century.”

Juliet Bakker said: “A hearing solution developed with the consumer in mind was long overdue. Eargo has truly put the consumer first, from consultations and solution design to the buying experience and highly rated customer support. We are delighted to partner with Eargo to help fuel the growth of this unique business.”

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU